The drug-maker allegedly used a charitable foundation to boost its own revenues by covering the copays of Medicare patients taking the company's drugs.
As healthcare prices escalate and the public looks for answers, America's Health Insurance Plans has launched a publicity campaign that it says breaks down how a premium dollar is spent.
Drug companies that may have engaged in 'shenanigans' to delay the entrance of cheaper competitors onto the market have raised prices and cost taxpayers more money over time.
Celgene tops the list of manufacturers being accused of 'gaming tactics' that can impede, or even halt, the development of generics.
Federal officials have expressed opposition to the idea, which still has a long way to go before it can be implemented.
The updated tools draw attention to year-over-year changes in drug prices.
Stakeholders said they appreciate the administration's vow to tackle rising drug costs, but they want to hear the specifics on when, where, and how these initiatives will be implemented.
IBM Watson compiles price fluctuation data over the past decade in the wholesale acquisition costs for the 10 most-frequently administered emergency department drugs.
Trade group fighting two fronts in the contentious debate over drug pricing.
The high court upholds the constitutionality of a patent appeals process that the health insurance industry says will help to negate stall tactics used by brand name drug makers.